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In seminal studies, Jules T. Freund reported that 
the presence of mycobacteria in a water-in-oil 
emulsion containing protein antigen stimulated a 
particularly strong delayed hypersensitivity reac-
tion in guinea pigs (Freund et al., 1950; Freund, 
1951). Later, it was shown that mycobacterial 
peptidoglycan (PGN) could replace whole my-
cobacterial cells in CFA (Lederer et al., 1975) 
and that synthetic N-acetylmuramyl-l-alanyl-d-
isoglutamine PGN moiety, usually referred to as 
N-acetyl muramyl dipeptide (MDP), presented 
adjuvant activity (Ellouz et al., 1974; Kotani 
et al., 1975). However, mycobacterial PGN is 
unique in that the N-acetyl group at carbon 2 
of muramic acid is preferentially hydroxylated 
to an N-glycolyl group (Adam et al., 1969) via 
the action of N-acetyl muramic acid hydroxy-
lase (NamH), an enzyme present only in certain 
aerobic Actinomycetes (Raymond et al., 2005). 
Notably, these are the very organisms to which 
Freund attributed increased immunogenic activ-
ity (Freund, 1956).
Adjuvants  act  by  stimulating  the  innate   
immune response of the host. The response   
to bacterial PGN is mediated largely by NOD1 
and NOD2, two members of the cytosolic-
  localized Nod-like receptor family, in coopera-
tion with other pattern recognition molecules 
such as Toll-like receptors (Kufer and Sansonetti, 
2007). NOD2 has been implicated in sens-
ing PGN-derived N-acetyl MDP and shown   
to activate the NF-B and mitogen-activated 
protein kinase (MAPK) pathways via polyubiq-
uitination of the RIP2 kinase (Girardin et al., 
2003; Yang et al., 2007; Hasegawa et al., 2008). 
However, the role of NOD2 in recognition of 
the unique mycobacterial N-glycolyl MDP has 
not been studied.
Using both bacterial genetics and chemical 
synthesis, we have determined the importance 
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Peptidoglycan-derived muramyl dipeptide (MDP) activates innate immunity via the host sensor 
NOD2. Although MDP is N-acetylated in most bacteria, mycobacteria and related Actinomy-
cetes convert their MDP to an N-glycolylated form through the action of N-acetyl muramic 
acid hydroxylase (NamH). We used a combination of bacterial genetics and synthetic chemistry 
to investigate whether N-glycolylation of MDP alters NOD2-mediated immunity. Upon infect-
ing macrophages with 12 bacteria, tumor necrosis factor (TNF)  secretion was NOD2 depen-
dent only with mycobacteria and other Actinomycetes (Nocardia and Rhodococcus). Disruption 
of namH in Mycobacterium smegmatis obrogated NOD2-mediated TNF secretion, which could 
be restored upon gene complementation. In mouse macrophages, N-glycolyl MDP was more 
potent than N-acetyl MDP at activating RIP2, nuclear factor B, c-Jun N-terminal kinase, and 
proinflammatory cytokine secretion. In mice challenged intraperitoneally with live or killed 
mycobacteria, NOD2-dependent immune responses depended on the presence of bacterial 
namH. Finally, N-glycolyl MDP was more efficacious than N-acetyl MDP at inducing ovalbu-
min-specific T cell immunity in a model of adjuvancy. Our findings indicate that N-glycolyl 
MDP has a greater NOD2-stimulating activity than N-acetyl MDP, consistent with the histori-
cal observation attributing exceptional immunogenic activity to the mycobacterial cell wall.
© 2009 Coulombe et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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shown (Raymond et al., 2005), the Mycobacterium smegmatis 
namH mutant was more susceptible to ampicillin than WT M. 
smegmatis and the mutant complemented with namH (Fig. 1 B, 
bottom). After ex vivo infection of WT and Nod2-deficient 
macrophages, NOD2-dependent TNF- production was 
abrogated in the absence of namH and restored with gene 
complementation (Fig. 1 B).
To verify that NOD2 recognition was sufficient for namH-
dependent TNF- production, we stimulated HEK293 cells 
transiently expressing NOD2 and a NF-B luciferase reporter 
vector with purified PGN derived from the Actinomycetes 
M. tuberculosis (namH positive) and Streptomyces sp. (namH 
negative). In this assay, M. tuberculosis–derived PGN, but not 
Streptomyces sp.–derived PGN, induced NF-B activation 
(Fig. 1 C). Therefore, namH is critical for optimal NOD2-
mediated recognition of mycobacterial PGN.
N-glycolyl MDP is sensed by NOD2 and is more potent  
than N-acetyl MDP at activating RIP2, NF-B,  
and c-Jun N-terminal kinase (JNK) but not p38 MAPK
Because mycobacterial PGN contains a mixture of N-gly-
colylated and N-acetylated muramic acid (Mahapatra et al., 
2005), we determined the relative capacity of N-acetyl and 
N-glycolyl MDP to stimulate NOD2-dependent responses. 
As shown in Fig. 2 A, both forms of MDP led to activation 
of NF-B in HEK293 cells expressing WT NOD2, but N-
glycolyl MDP was more stimulatory than N-acetyl MDP   
at 1 and 0.1 µg/ml. The Crohn’s disease (CD)–associated 
NOD2 variant containing a frame-shift mutation at position 
3,020 (NOD2fs) is unresponsive to N-acetyl MDP (Girardin 
et al., 2003). Likewise, the glycolylated variant was also un-
able to activate NF-B via the mutated NOD2 (Fig. 2 A).
The potency of a compound is a measure of its activity, 
as expressed by the concentration of compound required to 
produce a defined response. To determine the relative po-
tency of the two forms of MDP at activating intracellular 
signaling downstream of NOD2, we stimulated macrophages 
with increasing concentrations of these compounds ranging 
from 0.1 to 10 µg/ml. N-glycolyl MDP was 30-fold more   
potent than N-acetyl MDP at inducing polyubiquitination 
of RIP2 (Fig. 2 B), and 100-fold more potent than N-
  acetyl MDP at inducing phospho-IB (Fig. 2 C). Only 
N-glycolyl  MDP  could  induce  detectable  phospho-JNK 
under current experimental conditions (Fig. 2 D). Both 
forms  of  MDP  induced  similar  phosphorylation  of  p38 
MAPK (Fig. 2 E). Collectively, these data indicate that N-
glycolyl MDP is more potent than N-acetyl MDP at acti-
vating  NOD2-mediated  RIP2  polyubiquitination  and 
selective downstream pathways.
N-glycolyl MDP is more active than N-acetyl MDP  
at inducing synergistic proinflammatory cytokine production
It is known that MDP alone is a potent inducer of TNF- 
mRNA, which remains untranslated, and that presence of 
LPS abrogates this translation block (Wolfert et al., 2002). 
To compare N-glycolyl and N-acetyl MDP, we stimulated 
of the bacterial NamH enzyme for NOD2-mediated sensing 
and compared the activity of N-acetyl and N-glycolyl MDP 
in vitro and in vivo. Our findings identify N-glycolyl MDP as 
more stimulatory than N-acetyl MDP at eliciting NOD2-me-
diated immune responses in the context of an intact bacterium 
and as a pure compound. Together, these findings indicate 
that the NOD2 pathway may be exquisitely tuned to detect 
mycobacterial infections, and suggest a likely mechanism to 
explain the remarkable adjuvancy of mycobacterial cell walls.
RESULTS AND DISCUSSION
Macrophage recognition of selected Actinomycetes  
is NOD2 dependent
To address the effect of NOD2 on recognition of diverse bac-
teria, peritoneal macrophages derived from naive WT or 
Nod2-deficient mice were infected with a panel of live Gram-
negative and -positive organisms to measure TNF- secretion. 
As shown by others, naive macrophages produced undetect-
able levels of TNF- in response to N-acetyl MDP alone, and 
synergistic NOD2-dependent TNF- after co-stimulation 
with MDP and LPS (Fig. 1 A). After infection with Gram-
negative Escherichia coli, Salmonella typhimurium, and Pseudomo-
nas aeruginosa, and Gram-positive Bacillus cereus, Staphylococcus 
aureus, and Listeria monocytogenes, TNF- levels did not depend 
on NOD2 (Fig. 1 A). Conversely, as previously described for 
mycobacterial infection (Ferwerda et al., 2005; Ferwerda et al., 
2007; Gandotra et al., 2007; Divangahi et al., 2008; Leber   
et al., 2008), TNF- production was significantly reduced in 
Nod2-deficient cells after infection with different mycobacte-
rial species (Fig. 1 A). NOD2-dependent recognition extended 
to other Actinomycetales class members (Nocardia asteroides and 
Rhodococcus equi) but not Streptomyces sp. (Fig. 1 A).
As a trend, Nod2-deficient cells produced less TNF- af-
ter infection with Gram-positive but not Gram-negative or-
ganisms, consistent with the greater quantity of PGN in the 
cell wall of Gram-positive bacteria (Yang et al., 2001). How-
ever, the observation that significant NOD2-dependent rec-
ognition was restricted to a subset of aerobic Actinomycetes 
led us to ask whether these organisms in particular may share 
a common difference in their PGN.
Bacterial NamH is required for optimal  
NOD2-dependent recognition
Several differences in PGN amount, location, and structure 
exist among bacterial species and have in some instances been 
described to alter immunological activity (Stewart-Tull, 
1980). A common feature shared by NOD2-stimulatory Ac-
tinomycetes is the elaboration of N-glycolylated PGN via the 
action of the NamH hydroxylase that converts the UDP-N-
acetylmuramic acid PGN precursor moiety to UDP-N- 
glycolylmuramic acid (UDP-MurNAc + O2 + NADPH + 
H+ → UDP-MurNGlyc + NADP+ + H2O; Raymond et al., 
2005). Because hydroxylation of UDP-N-acetylmuramic 
acid ultimately affects the structure of MDP (Fig. 1 A, right), 
we tested the importance of namH for NOD2-dependent 
bacterial recognition through gene disruption. As previously JEM VOL. 206, August 3, 2009  1711
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10- to 20-fold lower concentration. (Fig. 3 A, bottom) The 
synergistic response to MDP plus TDM in Nod2+/+ cells was 
abrogated in Nod2/ cells (Fig. 3 B). Thus, N-glycolyl 
MDP is more stimulatory and more potent than N-acetyl 
MDP  at  inducing  proinflammatory  cytokine  production 
upon  co-stimulation  with  nonmycobacteria-  and  myco-
baceria-derived molecules.
WT M. smegmatis induces increased NOD2-dependent 
macrophage activation compared with namH-deficient  
M. smegmatis after i.p. challenge in mice
To investigate the effect of N-glycolyl MDP on in vivo in-
nate inflammatory response in the context of a live bacterial 
mouse peritoneal macrophages with various concentrations 
of MDP along with a fixed concentration of LPS, and mea-
sured TNF- and IL-6 production (Fig. 3 A, top). At all 
concentrations ranging from 0.5 to 10 µg/ml, N-glycolyl 
MDP was more stimulatory than N-acetyl MDP. In terms of 
potency,  N-glycolyl  MDP  was  active  at  a  10-fold  lower 
concentration than N-acetyl MDP (0.5 vs. 5 µg/ml). Be-
cause  Actinomycetes  do  not  produce  LPS,  we  repeated   
this experiment using M. tuberculosis–derived trehalose 6,6-
  dimycolate (TDM), a molecule that has been shown to have 
synergistic  immunological  activity  in  combination  with 
MDP (Masihi et al., 1985). Again, N-glycolyl MDP was   
more stimulatory than N-acetyl MDP and was active at a   
Figure 1.  NOD2-mediated recognition of selected Actinomycetes by macrophages depends on bacterial NamH. (A, left) Naive peritoneal macro-
phages from Nod2+/+ and Nod2/ mice were left unstimulated; stimulated with 10 µg/ml N-acetyl MDP alone, LPS alone, or a combination of N-acetyl MDP 
and LPS; or were infected with various live Gram-negative and -positive organisms. (right) Schematic representation of the effect of NamH on MDP. (B, top) 
Naive peritoneal macrophages from Nod2+/+ and Nod2/ mice were either left uninfected or were infected with WT M. smegmatis, namH-disrupted  
M. smegmatis (M. smegmatisnamH), and namH-disrupted M. smegmatis complemented with namH (M. smegmatisnamH::namH). (bottom) Ampicillin zone  
of inhibition assay on WT M. smegmatis and namH variants. In A and B, the amount of TNF- released in the supernatant after 16 h was quantified by ELISA. 
Results represent averaged data from two independent replicates (A) or one representative experiment out of three (B). (C) HEK293 cells were transfected 
with NOD2 and a NF-B luciferase reporter in the presence of PGN derived from indicated bacteria. The fold increase in NF-B activation compared with 
transfected but unstimulated cells was assessed. Representative data from three independent replicates are shown (means ± SEM). *, P < 0.05.1712 N-GLYCOLYL MDP AND NOD2 | Coulombe et al.
infection, we harvested and cultured peritoneal macrophages 
from Nod2+/+ and Nod2/ mice after i.p. stimulation with 
WT M. smegmatis, namH-deficient M. smegmatis, and namH-
complemented mutant. 3 d after infection, there was no sig-
nificant difference in the number of colony-forming units in 
the spleens of mice infected with the different organisms 
(unpublished data). Cells harvested from Nod2+/+ mice that 
had been infected with different strains of M. smegmatis spon-
taneously  released  low  levels  of  TNF-  (Fig.  4  A,  left). 
Nonetheless, cells from mice infected with namH-deficient 
M. smegmatis produced significantly less TNF- than cells 
from mice infected by either the WT or the complemented 
strain. Upon ex vivo restimulation of these cells with live 
mycobacteria, TNF- levels were increased, again in a namH-
dependent manner (Fig. 4 A, left). The namH dependence 
for both spontaneous cytokine production and restimulated 
cells was abrogated in Nod2/ mice. The same pattern was 
observed with IL-6 (Fig. 4 A, right).
Because the M. smegmatis namH mutant is more sensitive 
to lysozyme than WT M. smegmatis (Raymond et al., 2005), 
it is possible that infection with the former organism leads to 
increased PGN shedding and macrophage exhaustion rather 
than decreased stimulation. To control for this possibility, we 
digested the PGN from heat-killed M. smegmatis and namH 
variants, and performed a short-term i.p. stimulation of WT 
and Nod2-deficient mice. After 2 h, KC levels were signifi-
cantly increased in the peritoneum of WT mice stimulated 
with N-glycolyl MDP–containing organisms (Fig. 4 B, left). 
This increase was abrogated in Nod2-deficient mice. Further-
more, akin to what was observed after 72 h, macrophages re-
cruited to the peritoneum of WT mice after a 2-h challenge 
with M. smegmatis and the complemented namH mutant were 
more  responsive  to  Toll-like  receptor  4  stimulation  than 
macrophages from namH-deficient M. smegmatis–treated mice 
(Fig. 4 B, right). This effect was again dependent on the pres-
ence of NOD2 because it was abrogated in Nod2-deficient 
mice (Fig. 4 B, right). Thus, optimal NOD2-dependent macro-
phage activation by mycobacteria in vivo requires expression 
of the bacterial NamH.
N-glycolyl MDP confers increased immunological activity  
to live mycobacteria and is a critical active component of CFA
Our group recently showed that activation of the IFN-–IL-
12 axis during mycobacterial infection is impaired in Nod2-
deficient mice (Divangahi et al., 2008). To investigate the 
NOD2-dependent contribution of mycobacterial NamH to 
T cell activation, we performed a short-term immunization 
experiment using live WT M. smegmatis and namH-deficient 
Figure 2.  N-glycolyl MDP is more potent than N-acetyl MDP at 
inducing RIP2 polyubiquitination and at activating NF-B and 
JNK. (A) HEK293 cells were transfected with indicated vectors and a 
NF-B luciferase reporter in the presence of various concentrations of 
N-glycolyl or N-acetyl MDP. Fold increase in NF-B activation com-
pared with transfected but unstimulated cells was assessed. Represen-
tative data from three independent replicates are shown (means ± 
SEM). *, P < 0.05 compared with unstimulated cells; **, P < 0.05 be-
tween N-glycolyl versus N-acetyl MDP. (B–E) RAW 264.7 cells were left 
untreated or treated with various concentrations of N-acetyl or N-
glycolyl MDP. (B) Cell lysates were immunoprecipitated (IP) and polyu-
biquitinated RIP2 proteins were detected by immunoblotting (IB) with 
the indicated antibody. Total immunoprecipitated RIP2 protein was 
measured as a control. (C–E) The NF-B (C), JNK (D), and p38 MAPK (E) 
activities were measured by immunoblotting with the indicated anti-
phospho antibodies. Total IB, JNK, p38 MAPK, and -tubulin protein 
levels were measured with the indicated antibodies. Representative 
data from two independent replicates are shown in B–E. Black lines 
indicate that intervening lanes have been spliced out.
 JEM VOL. 206, August 3, 2009  1713
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To specifically test the relative adjuvant activity of the two 
forms of MDP present in CFA, we immunized mice s.c. with 
preparations of OVA emulsified in (a) IFA alone, (b) CFA, (c) 
N-glycolyl MDP with IFA, or (d) N-acetyl MDP with IFA. 
After  7  d,  OVA-specific  IFN-–producing  cells  from  the 
draining lymph nodes were enumerated by ELISPOT. IFA 
alone was not sufficient to generate antigen-specific immu-
nity, whereas CFA induced a high frequency of OVA-specific 
IFN-–producing T cells (Fig. 5 B). Strikingly, N-glycolyl 
MDP plus IFA induced a comparable response to CFA, which 
M. smegmatis. 14 d after immunization, no bacteria could be 
detected in the mouse spleens (unpublished data). As shown 
in Fig. 5 A, the number of IFN-–producing splenocytes 
(top) and the level of IFN- production by these cells (mid-
dle) were significantly increased in Nod2+/+ compared with 
Nod2/ cells after immunization with WT M. smegmatis. 
This NOD2 dependence was lost after immunization with 
namH-deficient M. smegmatis. Similar results were obtained 
when measuring IL-12p40 production by splenic antigen-
presenting cells (Fig. 5, bottom).
Figure 3.  N-glycolyl MDP is more potent than N-acetyl MDP at inducing proinflammatory cytokine production in macrophages. (A) Naive 
peritoneal macrophages from Nod2+/+ mice were stimulated for 6 h with LPS (top) or for 12 h with TDM (bottom) in combination with various concentra-
tions of N-glycolyl or N-acetyl MDP. (B) Naive peritoneal macrophages from Nod2+/+ and Nod2/ mice were either left unstimulated or were stimulated 
for 12 h with 10 µg/ml N-acetyl MDP alone, 10 µg/ml N-glycolyl MDP alone, TDM alone and a combination of N-acetyl MDP and TDM, or N-glycolyl MDP 
and TDM. The amount of TNF- and IL-6 released in the supernatant was quantified by ELISA. Representative data from three independent replicates are 
shown (means ± SEM). *, P < 0.05 compared with no MDP added; **, P < 0.05 between N-glycolyl versus N-acetyl MDP.1714 N-GLYCOLYL MDP AND NOD2 | Coulombe et al.
NOD2 is a susceptibility gene for CD, a polygenic sys-
temic inflammatory disease featuring recurring lesions in the 
gastrointestinal tract (Hugot et al., 2001). Cells from humans 
with CD-associated NOD2 polymorphisms manifest a re-
duced response to MDP (Inohara et al., 2003), which could 
increase susceptibility to intracellular bacterial infection.   
Because only a small minority of all individuals with CD-asso-
ciated NOD2 polymorphisms will develop CD in their   
lifetime, it is possible that decreased resistance to specific 
bacteria will play an important role in disease pathogenesis. 
Given the importance of NOD2 as a key modulator of the 
host  response  to  N-glycolyl  MDP–containing  bacteria,  it 
will be a priority to investigate the role of these organisms in 
the pathogenesis of CD.
MATERIALS AND METHODS
Mice. Nod2+/ males backcrossed six generations onto a C57BL/6 back-
ground were obtained from the Congenics Facility at Yale University. They 
were bred with C57BL/6 mice purchased from Harlan Laboratories to estab-
lish a Nod2/ breeding colony at the McGill University Health Centre.   
was significantly greater than N-acetyl MDP plus IFA. As a 
control, there was no response in nondraining lymph nodes 
(unpublished data). These results point to a key role of N-gly-
colylated MDP in the adjuvant activity of CFA.
Concluding remarks
The major findings of this work are that the disruption of 
namH leads to impaired NOD2-mediated recognition of my-
cobacterial PGN, and that N-glycolyl MDP is more potent at 
modulating host response compared with N-acetyl MDP. 
Thus, it appears that the mammalian NOD2 pathway is ex-
quisitely sensitive to PGN from mycobacteria and related or-
ganisms, and hence, that NOD2 serves as a major receptor 
for CFA. Efforts are currently underway to address the role of 
NamH in relationship to NOD2 using more virulent bacte-
rial organisms. Determining whether increased potency of 
N-glycolyl MDP is a result of altered affinity, stability, or cy-
tosolic delivery is expected to lead to a better understanding 
of the mechanism of action of CFA.
Figure 4.  Increased NOD2-dependent immunogenicity of WT M. smegmatis compared with M. smegmatisnamH during short-term mouse 
i.p. challenge. (A) Naive Nod2+/+ and Nod2/ mice (n = 3 per genotype per infection) were injected i.p. with live preparations of either M. smegmatis,  
M. smegmatisnamH, or M. smegmatisnamH::namH. After 72 h, peritoneal macrophages were harvested and either left unstimulated or stimulated with 
M. smegmatisnamH. (B) Naive Nod2+/+ and Nod2/ mice (n = 3 per genotype per stimulation) were injected i.p. with mutanolysin-treated killed prepa-
rations of either M. smegmatis, M. smegmatisnamH, or M. smegmatisnamH::namH. After 2 h, peritoneal lavage was performed, and peritoneal macro-
phages were harvested and either left unstimulated or stimulated with LPS. The amount of KC in the peritoneal lavage as well as TNF- and/or IL-6 
released in the culture supernatant was quantified by ELISA. Representative data from two independent replicates are shown (means ± SEM). *, P < 0.05.JEM VOL. 206, August 3, 2009  1715
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A WT breeding colony was established from the Nod2+/+ littermates from 
this breeding, and these animals were used for experiments in Figs. 1, 3, 4, and 
5 A. For Fig. 5 B, C57BL/6 mice were purchased from the Jackson Labora-
tory. All study mice were 8–12 wk old, and experiments were conducted in 
accordance with the guidelines of animal research ethics boards of McGill 
and Harvard Universities.
Bacterial strains, growth conditions, and bacteria-derived reagents. 
M. bovis BCG Russia, M. smegmatis mc2155, and M. avium ssp. paratuberculo-
sis (MAP) K10 were grown as previously described (Divangahi et al., 2008). 
For MAP K10, 1 µg/ml mycobactin J (Allied Monitor Inc.) was added to 
the culture medium. S. aureus (American Type Culture Collection), E. coli 
(American Type Culture Collection), S. typhimurium (American Type Cul-
ture Collection), P. aeruginosa (American Type Culture Collection), and 
recent clinical isolates of L. monocytogenes, B. cereus, R. equi, N. asteroides, and 
Streptomyces sp., as well as E. coli DH5- used for cloning purposes, were 
cultured at 37°C in Luria broth (Difco) at 250 rpm. Kanamycin (50 µg/ml 
for E. coli and mycobacteria) and hygromycin (100 µg/ml for E. coli and   
50 µg/ml for mycobacteria) were used when needed.
Pure LPS from E. coli 055:B5, N-acetyl MDP (98% purity), Streptomyces 
sp.–derived PGN, TDM from M. tuberculosis (99% purity), CFA, and IFA 
were purchased from Sigma-Aldrich. M. tuberculosis–derived PGN was a gift 
from P. Brennan and J. Spencer (Colorado State University, Fort Collins, 
CO). N-glycolyl MDP was custom synthesized (Carbohydrate Synthesis; 
Kobayashi et al., 1980) and shown to be >95% pure by nuclear magnetic 
resonance spectrometry. N-acetyl and N-glycolyl MDP were free of endo-
toxin contamination, as confirmed by the Limulus amebocyte lysate assay 
(Pyrotell; Associates of Cape Cod, Inc.).
Construction and complementation of the M. smegmatis namH mu-
tant. The hygromycin resistance cassette from PSC301 was digested by 
XmnI and inserted into XbaI-digested and T4 polymerase-treated pUC19 to 
generate the pUC19::Hyg suicide vector. Subsequently, a 1,070-bp fragment 
derived from the M. smegmatis namH gene (amplified using KONamHF [5-
CCGCATATGTCGCCTCGTGGTTC-3] and KONamHR [5-AGCG-
GATCCTCTCGTCGGGGATC-3]) was inserted into pUC19::Hyg using 
NdeI and BamHI. This plasmid was electroporated in M. smegmatis, and the 
hygromycin-resistant clones were confirmed by Southern blotting to have 
the plasmid inserted in namH. To complement the ∆namH mutant, the full-
length M. smegmatis namH gene was amplified along with its putative pro-
moter using MsNamHF (5-CGAGCTAGCTGGTGTGGTTGATCG-3) 
and MsNamHR (5-GATAAGCTTCGATGTGCCCGACG-3). This 
fragment was inserted in pSUM37 using NheI and HindIII to generate the 
pSUMnamH complementation vector.
Ex vivo macrophage culture, infection, and stimulation. Peritoneal 
macrophages were harvested from naive Nod2+/+ and Nod2/ mice with-
out prestimulation. 105 cells per well were purified by adherence and cul-
tured in 96-well plates with or without live bacterial infection (2 CFU/cell) 
or stimulation with 10 ng/ml LPS, 10 µg/ml TDM, and N-acetyl and N-
glycolyl MDP. TDM was dissolved in petroleum ether, coated to the wells 
of a 96-well plate, and allowed to evaporate before macrophage addition 
with and without MDP. The culture supernatants were collected at desig-
nated intervals and stored at 20°C until cytokine measurements. Cytokine 
production by macrophages was assayed using ELISA (R&D Systems) to 
measure TNF- and IL-6 in culture supernatants.
Antibiotic sensitivity assay. 107 cells from log-phase M. smegmatis strains 
were resuspended in 200 µl 7H9 and spread onto 25 ml 7H10 in standard 
15-cm-diameter  Petri  dishes.  10-µg  ampicillin  disks  (Oxoid  Ltd.)  were 
placed on inoculated plates. After a 48-h incubation at 37°C, the diameter of 
the zone of inhibition was measured.
HEK293 cell transfection and stimulation. Plasmids containing cDNA 
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14 d later with the same organism. Saline-injected mice were used as a 
control. The frequency of IFN-–producing splenocytes (top) as well as 
total IFN- (middle) and IL-12p40 (bottom) production by these cells 
was quantified using ELISPOT and ELISA, respectively. (B) C57BL/6 mice 
(n = 3–4 per immunization) were immunized s.c. with the indicated 
emulsified preparations for 7 d. The frequency of OVA-specific IFN-–
producing T cells in the draining lymph nodes was analyzed by ELISPOT 
of unstimulated and OVA-stimulated cells. Representative data from two 
independent replicates are shown (means ± SEM). *, P < 0.05.1716 N-GLYCOLYL MDP AND NOD2 | Coulombe et al.
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(NOD2fs) were gifts from S. Girardin (University of Toronto, Toronto, 
Canada). 3xFLAG-tagged NOD2wt and NOD2fs were PCR amplified and 
subcloned into the pIRES-puro3 expression vector (Clontech Laboratories, 
Inc.). For NF-B activation assays, 105 HEK293 cells per well were seeded 
into 24-well plates and transfected overnight using FuGene6 (Roche) with 
1 ng of NOD2, NOD2fs, or empty vector, 75 ng pTAL-NF-B-luc (Clon-
tech Laboratories, Inc.), and 7.5 ng pGL4-RL (Promega), along with de-
fined concentrations of PGN or MDP. After 16 h, a dual-luciferase reporter 
assay (Promega) was performed on cell lysates.
Immunoprecipitation and Western blot analysis. Immunoprecipita-
tion and immunoblotting were performed as previously described (Yang   
et al., 2007). Experiments were performed using the RAW 264.7 macro-
phage cell line stimulated with MDP for 1 h.
i.p. M. smegmatis challenges. Nod2+/+ and Nod2/ mice were injected i.p. 
with 0.5 ml PBS containing 107 live or heat-killed, mutanolysin-treated M. 
smegmatis (Sigma-Aldrich) or modified strains for 72 and 2 h, respectively. 
Peritoneal lavage was performed at 2 h with 3 ml PBS, and peritoneal macro-
phages from infected mice were harvested and cultured as described with or 
without stimulation. KC production in the peritoneal lavage as well as TNF- 
and IL-6 production in culture supernatants was assayed using ELISA.
Immunizations and analysis of T cell response. Nod2+/+ and Nod2/ 
mice were immunized i.p. with 0.5 ml PBS alone or containing 106 live 
M. smegmatis or M. smegmatisnamH. After 14 d, each mouse was given a 5-d 
boost with the same preparation used for immunization. The number of 
IFN-–producing splenocytes (0.5 × 106/well) as well as total IL-12p40 and 
IFN-  production  by  unstimulated  cells  was  measured  using  ELISPOT 
(R&D Systems) and ELISA, respectively.
C57BL/6 mice received s.c. injections (two injection sites, 100 µl per site) 
of 200 µg OVA (Sigma-Aldrich) mixed with IFA, CFA, 30 µg N-glycolyl MDP 
plus IFA, or 30 µg N-acetyl MDP plus IFA. 7 d after immunization, a single-cell 
suspension was prepared from draining lymph nodes (inguinal) and nondraining 
lymph nodes (axillary). Cells were incubated for 24 h with medium alone or 
containing 100 µg OVA, and then subjected to IFN- ELISPOT.
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